Australia's Beamtree rises as co extends distribution deal with U.S.-based Abbott

Beamtree Holdings

30/03/2022 04:42

** Shares of Beamtree Holdings  BMT.AX  rise as much as 3%
to A$0.345, their biggest intraday pct jump since March 24
    ** Co says https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02504404-2A1365630?access_token=83ff96335c2d45a094df02a206a39ff4
 it reached a transitional deal with U.S.-based medical devices
maker Abbott Laboratories  ABT.N  to extend their distribution
agreement for another six months
    ** Adds that Beamtree will continue to earn a licence fee
for every new Abbott client signed during the extended period
    ** Beamtree set for a second straight session of gains; but
set to lose more than 30% over the quarter, its worst since
March 2020 quarter

 (Reporting by Sameer Manekar in Bengaluru)
 ((Sameer.Manekar@thomsonreuters.com; Twitter: https://twitter.com/sameer_manekar))